China Securities Co.Ltd(601066)
about
Tinavi Medical Technologies Co.Ltd(688277) issue shares to specific objects in 2021
And listed on the scientific innovation board
of
Listing recommendation
Sponsor
December, 2001
Statement of recommendation institution and recommendation representative
China Securities Co.Ltd(601066) and sun Dong, the sponsor representative of the project According to the company law of the people’s Republic of China (hereinafter referred to as the company law) and the securities law of the people’s Republic of China (hereinafter referred to as the Securities Law) ）And other relevant laws and regulations and the relevant provisions of the CSRC and the Shanghai Stock Exchange, be honest, trustworthy, diligent and responsible, issue the listing recommendation letter in strict accordance with the business rules and industry self-discipline norms formulated according to law, and ensure that the documents issued are true, accurate and complete.
catalogue
interpretation…… 3 I. Basic information of the issuer 5. II. The issuer’s current offering III. information about the sponsor representatives, CO sponsors and other members of the project team for this securities issuance and listing, including personnel names, implementation of sponsor business, etc 17 IV. explanation on whether the recommendation institution has any circumstances that may affect the fair performance of recommendation duties V. internal audit procedures and core opinions of the recommendation institution on this securities issuance Vi. matters that the recommendation institution should undertake in accordance with relevant provisions VII. The sponsor’s explanation on whether the issuer has fulfilled the decision-making procedures stipulated in the company law, the securities law and the CSRC and Shanghai stock exchange with respect to the issuance and listing of Securities 22 VIII. Work arrangement during continuous supervision 26 IX. recommendation conclusion of the sponsor on the project twenty-eight
interpretation
In this listing recommendation letter, unless otherwise specified, the following words have the following specific meanings: recommendation institution, lead underwriter, middle finger China Securities Co.Ltd(601066) credit construction investment securities company, issuer, Tinavi Medical Technologies Co.Ltd(688277) refers to Tinavi Medical Technologies Co.Ltd(688277) controlling shareholder and actual controller
Company law means the company law of the people’s Republic of China
Securities Law means the securities law of the people’s Republic of China
General meeting means Tinavi Medical Technologies Co.Ltd(688277) general meeting of shareholders
Board of directors means the Tinavi Medical Technologies Co.Ltd(688277) board of directors
Board of supervisors means Tinavi Medical Technologies Co.Ltd(688277) the board of supervisors
Articles of association and articles of association refer to the Tinavi Medical Technologies Co.Ltd(688277) articles of association
CSRC refers to the China Securities Regulatory Commission
Shanghai stock exchange refers to Shanghai Stock Exchange
The measures for the administration of the registration of the science and Innovation Board refer to the measures for the administration of the registration of securities issuance of listed companies on the science and Innovation Board (Trial)
(row)
The current issuance to specific objects refers to the issuance of shares to specific objects in Tinavi Medical Technologies Co.Ltd(688277) 2021
A shares and shares refer to RMB ordinary shares with a par value of RMB 1.00 per share issued by the company
Yuan means RMB yuan (except as specifically mentioned herein)
Pricing base date refers to the base date for calculating the issue reserve price
Mazor robotics refers to mazor robotics Ltd., an Israeli orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) manufacturer, which was later acquired by Medtronic
Mako surgical company refers to Mako surgical Corp., an American joint replacement Siasun Robot&Automation Co.Ltd(300024) manufacturer, which was later acquired by Stryker
MedTech company refers to MedTech S.A.S, a French surgical Siasun Robot&Automation Co.Ltd(300024) manufacturing enterprise, which was later acquired by Gemini bangmei
Medtronic Inc (Medtronic), founded in 1949, is headquartered in the United States, and is the world’s largest medical technology company Medtronic. It provides lifelong treatment for patients with chronic diseases, including cardiovascular group, restorative therapy group, minimally invasive treatment group and diabetes business group.
Stryker Corporation, founded in 1946 and headquartered in the United States, is one of the largest orthopedic and medical technology companies in the world, with 14 production, R & D and sales divisions around the world
Zimmer Biomet, founded in 1927 and headquartered in the United States, is committed to the design, R & D, manufacturing and marketing of orthopaedic reconstruction, spinal cord and trauma instruments, artificial dental implants and related surgical products
Xinjun refers to Shenzhen xinjunte Intelligent Medical Instrument Co., Ltd
State Food and drug administration. In March 2013, the State Food and drug administration was established. In March 2018, according to the requirements of the plan for deepening the institutional reform of the party and the state, CFDA and the State Food and Drug Administration mean that the State Food and Drug Administration and the State Administration for Industry and commerce were integrated into the state market supervision and administration, and a separate state drug administration was established, which is managed by the state market supervision and administration
Nmpa and the State Food and Drug Administration refer to the national medical administration
Products Administration (nmpa)
National Health Commission and National Health Commission refer to the health commission of the people’s Republic of China, which was officially listed in March 2018 and assumed the responsibilities of the former national health and Family Planning Commission and other departments
The state health and Family Planning Commission and the health and Family Planning Commission refer to the health and Family Planning Commission of the people’s Republic of China
The State Ministry of industry and information technology and the Ministry of industry and information technology refer to the Ministry of industry and information technology of the people’s Republic of China
Ministry of science and technology means the Ministry of science and technology of the people’s Republic of China
Any discrepancy between the total number and the mantissa of the sum of the itemized values in this listing recommendation letter shall be caused by rounding.
1、 Basic information of the issuer (I) overview of the issuer
Chinese name Tinavi Medical Technologies Co.Ltd(688277)
English Name: tinavi medical technologies Co., Ltd
Incorporated on October 22, 2010
The registered capital is 41984684800 yuan
Legal representative: Zhang Songgen
Secretary of the board of directors Huang Junhui
Company domicile: room 206, 2f, building 1, Zone C, Dongsheng Science Park, No. 66, xixiaokou Road, Haidian District, Beijing
Stock Exchange Shanghai Stock Exchange
Stock abbreviation Tinavi Medical Technologies Co.Ltd(688277)
Stock Code: 688277
Tel: 010-82156660-8009
company website https://cn.tinavi.com.
Technology development, technical consultation, technology transfer and technical services; General construction contracting, professional contracting and labor subcontracting; Sales of electronic products, mechanical equipment, class I medical devices and class II medical devices; Economic information consultation; Import and export of goods, import and export of technology and import and export agency; Sales of class III medical devices (subject to the business scope approved in the medical device business enterprise license); production of medical devices (class I, II and III) (subject to the scope approved in the medical device manufacturing enterprise license). (market entities shall independently choose business items and carry out business activities according to law; projects that must be approved according to law shall carry out business activities according to the approved contents after being approved by relevant departments; they shall not engage in business activities of projects prohibited and restricted by national and municipal industrial policies.)
（2） The issuer’s main business, core technology and R & D level
1. Main business
The issuer is a leading enterprise in China’s orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) industry, always focusing on the R & D, production, sales and service of orthopaedic surgery navigation positioning Siasun Robot&Automation Co.Ltd(300024) . The issuer is committed to promoting the application and popularization of surgical assistance Siasun Robot&Automation Co.Ltd(300024) in clinic, helping doctors carry out surgery more accurately, efficiently and safely, and improving the quality of life of patients, so as to lead orthopaedic surgery into the era of Siasun Robot&Automation Co.Ltd(300024) intelligent assistance.
After years of technology accumulation and market development, the issuer has formed a product innovation and R & D system guided by “production, learning, research and medicine”. Starting from the clinical needs of Orthopaedic Surgery, integrating the research results of famous universities and the clinical experience of authoritative hospitals, through professional industrial design, production and clinical trials, the issuer’s R & D team has successfully developed three generations of products, namely “GD-A”, “GD-2000 / gd-s” “Tirobot” (also known as “Tianji”) and “tirobot forcepro superior / tirobot forcepro spine” (also known as “Tianji 2.0”) have obtained the class III medical device registration certificate issued by CFDA. The issuer’s second-generation and third-generation orthopaedic surgery navigation Siasun Robot&Automation Co.Ltd(300024) It has entered the stage of clinical promotion, and the sales scale increased rapidly during the reporting period.
The issuer’s orthopaedic surgery navigation and positioning Siasun Robot&Automation Co.Ltd(300024) product is one of the representatives of China’s industrialized scientific and technological innovation products, which was displayed at the national “12th Five Year Plan” scientific and technological innovation achievement exhibition in June 2016; In November 2018, it was exhibited in the “big country meteorology” exhibition area of “great change – large exhibition celebrating the 40th anniversary of reform and opening up”; At the first China International Import Expo in November 2018, together with 7 exhibits such as large aircraft, supercomputer, high-speed railway and Hong Kong Zhuhai Macao Bridge, it was selected as the China Pavilion of the “National Exhibition”.
The issuer has undertaken or participated in the scientific research tasks of “National Science and technology support plan”, “national key R & D plan” and “Beijing Science and technology plan”. The issuer’s second-generation product GD-2000 won the national key new product certificate in 2014. The issuer applied for the project of “establishment and clinical application of intelligent orthopaedic surgery system based on image navigation and Siasun Robot&Automation Co.Ltd(300024) technology” as the third unit, and won the second prize of 2015 National Science and Technology Progress Award and the first prize of 2014 Beijing Science and Technology Award; The issuer completed the project of “key technology R & D and clinical application of general orthopaedic navigation surgery Siasun Robot&Automation Co.Ltd(300024) system” as the third unit, and won the first prize of Beijing Science and Technology Award in 2018. In 2018, with the support of the Ministry of industry and information technology, the National Health Commission, the State Food and Drug Administration and other departments, The Ministry of science and technology selected and reviewed the Innovation Medical Management Co.Ltd(002173) instrument product catalog (2018). The issuer’s third-generation product “Tianji” orthopaedic surgery navigation Siasun Robot&Automation Co.Ltd(300024) is the only “international original” product in the category of treatment equipment and instruments. According to the agreement on agreeing 21 leading hospitals such as Beijing Jishuitan hospital to create orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) issued by the Ministry of industry and information technology and the Commission of health in November 2017 Notice of Application Center (gxtz [2017] No. 638)
